Nobilis Health Corp.
NHC.TO
TSX
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -12.98% | -3.40% | 3.64% | 16.44% | 27.93% |
| Total Other Revenue | 13.36% | -8.19% | 13.22% | 6.47% | 7.81% |
| Total Revenue | -12.32% | -3.54% | 3.91% | 16.14% | 27.34% |
| Cost of Revenue | -6.03% | -2.20% | 2.64% | 6.40% | 20.03% |
| Gross Profit | -15.90% | -4.33% | 4.70% | 22.48% | 31.90% |
| SG&A Expenses | -20.43% | -11.90% | -4.30% | 14.73% | 31.06% |
| Depreciation & Amortization | 73.09% | 60.40% | 31.37% | 25.22% | 22.69% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.82% | -5.87% | -0.39% | 11.61% | 26.23% |
| Operating Income | -18.52% | 36.08% | 118.70% | 107.25% | 42.58% |
| Income Before Tax | 0.45% | 40.44% | 100.89% | 44.19% | -34.53% |
| Income Tax Expenses | 62.67% | 185.27% | 189.73% | 126.65% | 128.54% |
| Earnings from Continuing Operations | -36.85% | -19.85% | 44.76% | -64.03% | -77.99% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.31% | -164.86% | -892.96% | -555.81% | -767.94% |
| Net Income | -71.65% | -74.01% | -41.12% | -77.16% | -89.57% |
| EBIT | -18.52% | 36.08% | 118.70% | 107.25% | 42.58% |
| EBITDA | 7.13% | 44.33% | 78.47% | 75.41% | 36.39% |
| EPS Basic | -71.94% | -74.28% | -40.46% | -78.65% | -90.25% |
| Normalized Basic EPS | -13.81% | -19.34% | 3.82% | -38.94% | -69.06% |
| EPS Diluted | -74.41% | -75.83% | -34.16% | -78.40% | -90.64% |
| Normalized Diluted EPS | -13.46% | -18.43% | 5.29% | -35.96% | -67.61% |
| Average Basic Shares Outstanding | 0.88% | 1.10% | 1.97% | 3.33% | 5.03% |
| Average Diluted Shares Outstanding | 1.99% | 0.85% | 1.71% | 2.29% | 1.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
